Memorial Sloan Kettering Cancer Center

Parking costs at cancer treatment centers — including those with the highest standard of care — can be a source of financial toxicity for patients and caregivers, according to a research letter published in JAMA Oncology.

Cellular senescence has both positive and negative effects in the body.

The Society for Immunotherapy of Cancer announced the results of its 2020 election, conducted this spring.

The FDA cleared an investigational new drug application for FT819, a chimeric antigen receptor T-cell therapy for the treatment of CD19-positive tumors, according to a press release from the agent’s manufacturer.

For decades, the 5-year survival rate for patients with advanced bladder cancer has remained at about 35%.

Patients with cancer who contract COVID-19 may be at a higher risk for hospitalization and severe disease if they are undergoing treatment with immune checkpoint inhibitors, according to results of a retrospective study published in Nature Medicine.

Young adults with early-onset cancers appeared at increased risk for harboring specific germline mutations, according to study results presented at the American Association for Cancer Research Virtual Annual Meeting II.

Researchers linked early discontinuation of venetoclax to shorter progression-free survival and impacted overall survival in relapsed or refractory chronic lymphocytic leukemia but interruption of venetoclax was not.

The first two doses of nivolumab with ipilimumab appeared to drive efficacy and toxicity of the combination among certain patients with melanoma, according to phase 2 study results presented during the ASCO20 Virtual Scientific Program.

Fellows of the American Association for Cancer Research Academy named Charles L. Sawyers, MD, president-elect for 2020-2021.